series-c-plus
Stage
1
Investors
About
Protalix Biotherapeutics is a biopharmaceutical company that develops and manufactures recombinant therapeutic proteins using plant cell-based expression technology.
Explore Protalix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.